title: Monitoring patients on antimalarials: where are we now?
authors.forename: Michael
authors.initials: M
authors.lastname: Easterbrook
mesh_terms: D000047:Academies and Institutes / Q000592:standards; D000962:Antimalarials / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy; D001824:Body Constitution; D003117:Color Vision Defects / Q000139:chemically induced* / Q000175:diagnosis; D016903:Drug Monitoring; D004596:Electroretinography; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008875:Middle Aged; D009885:Ophthalmology / Q000592:standards; D017410:Practice Guidelines as Topic; D012160:Retina / Q000187:drug effects*; D012607:Scotoma / Q000139:chemically induced* / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D014481:United States; D014794:Visual Fields / Q000187:drug effects*
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine